Respiratory Motion lands 510(k) Clearance for its ExSpiron Monitor, which provides a quantitative tool to help clinicians keep a constant watch on non-ventilated patients.

Massachusetts-based medical device maker Respiratory Motion won FDA approval for its ExSpiron respiratory monitoring system, the 1st monitor to provide continuous, noninvasive minute ventilation data to improve safely in non-ventilated patients.

Minute ventilation data, the amounts of air that enter and leave the lungs every minute, have not been previously available to doctors "across the continuum of care," according to the company.